Earnings per share (EPS) climbed to 1.08 cents in the 2HFY2021 from 0.91 cents a year ago on a fully diluted basis.
Medical oncology and stem cell services provider TalkMed Group saw its earnings jump 18.5% to $14.3 million for the 2HFY2021 ended December, from $12.1 million a year ago.
This brings earnings for the FY2021 to $25.1 million, 10.3% higher y-o-y.
